세계의 리드리스 페이싱 시스템 시장 : 업계 분석, 규모, 점유율, 성장, 동향, 예측(2024-2031년)

Leadless Pacing System Market: Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2024-2031

US $ 4,995 ￦ 6,828,000

Unprintable PDF & Excel (Single User License)

PDF, Excel 보고서를 1명만 이용할 수 있는 라이선스입니다. 텍스트의 복사, 인쇄가 불가능합니다.

US $ 7,295 ￦ 9,972,000

PDF & Excel (Multi User License)

PDF, Excel 보고서를 동일 기업 내 5명까지 이용할 수 있는 라이선스입니다. 텍스트의 Copy&Paste와 인쇄가 가능합니다.

US $ 8,495 ￦ 11,613,000

PDF & Excel (Corporate User License)

PDF, Excel 보고서를 동일 기업의 모든 분이 이용할 수 있는 라이선스입니다. 텍스트의 Copy&Paste와 인쇄가 가능합니다.

한글목차

이 보고서는 세계 리드리스 페이싱 시스템 시장을 조사했으며, 응용 유형별, 최종 사용자별, 지역별 동향, 시장 진출기업 프로파일 등의 정보를 제공합니다.

목차

제1장 주요 요약

제2장 시장 소개

제3장 리드리스 페이싱 시스템 시장의 시점

• 세계 시장 역학
• 거시경제 요인
• 기회 분석

제4장 북미의 리드리스 페이싱 시스템 시장 분석 및 예측

제5장 라틴아메리카의 리드리스 페이싱 시스템 시장 분석 및 예측

제6장 유럽 리드리스 페이싱 시스템 시장 분석 및 예측

제7장 아시아태평양의 리드리스 페이싱 시스템 시장 분석 및 예측

제8장 중동 및 아프리카의 리드 레스페이싱 시스템 시장의 분석과 예측

제9장 경쟁 구도

• 경쟁 대시보드
• 시장 점유율 분석(2024년)
• 기업 프로파일(상세 - 개요, 재무, 전략, 최근 동향)
• 주요 기업
  • Abbott Laboratories
  • Medtronic Plc

제10장 세계의 리드리스 페이싱 시스템 시장의 분석과 예측 :지역별

• 소개
• 시장 규모 분석 :지역별
• 시장의 매력 분석 : 지역별

제11장 세계의 리드리스 페이싱 시스템 시장의 분석과 예측 : 응용 유형별

제12장 세계의 리드리스 페이싱 시스템 시장 분석 및 예측 : 최종 사용자별

제13장 세계의 리드리스 페이싱 시스템 시장의 분석과 예측

제14장 사용된 전제조건과 약어

제15장 조사 방법

JHS

영문 목차

영문목차

Persistence Market Research has recently released a comprehensive report on the global Leadless Pacing Systems Market, providing an in-depth analysis of key market dynamics, including driving forces, emerging trends, opportunities, and challenges. This report offers a detailed understanding of the market landscape, helping stakeholders make well-informed decisions.

Key Insights:

• Leadless Pacing Systems Market Size (2024): US$ 53.5 Mn
• Projected Market Growth Value (2031F): 102.4 Mn
• Global Market Growth Rate (CAGR 2024 to 2031): 9.7%

Leadless Pacing Systems Market - Report Scope:

Leadless pacing systems represent a significant innovation in the cardiac pacemaker industry, offering a less invasive alternative to traditional pacemakers. These systems eliminate the need for leads, reducing complications such as lead and pacemaker pocket issues. While limited to single-chamber ventricular pacing, leadless devices are proving to be effective for conditions like permanent atrial fibrillation, sinus node dysfunction, and atrioventricular block. The devices are implanted through a vein near the thigh, and retrieval is possible without complications, as confirmed by clinical studies. High implant success rates have been recorded in various trials, including St. Jude's Nanostim with a 97% success rate.

Market Growth Drivers:

The growth of the leadless pacing systems market is driven by several factors, including a rise in eligible patients, better reimbursement scenarios, increased disposable income, and growing preference for advanced technologies. Additionally, the aging population, higher rates of cardiovascular diseases, and expanding medical insurance are further propelling market expansion. The technology's benefits, such as its less invasive nature, long battery life, and the ability to provide relief from frequent pacing, are key factors supporting the market's growth.

Market Restraints:

Despite the positive growth outlook, the leadless pacing systems market faces certain challenges. Strict regulatory approvals, high product costs, and a limited number of operators with hands-on experience restrict market expansion. Battery depletion issues also pose a challenge to the widespread adoption of these devices. Furthermore, there is a need for professional education and training to increase the number of qualified professionals capable of performing these procedures.

Market Opportunities:

There are significant opportunities for growth in the leadless pacing systems market, particularly through advancements in dual-chamber and multi-chamber pacing systems. Companies have the potential to enhance product penetration by offering better training programs for medical professionals and expanding their distribution networks. Additionally, increasing awareness and improving healthcare infrastructure in emerging markets present growth opportunities for manufacturers.

Key Questions Answered in the Report:

• What are the primary factors driving the growth of the leadless pacing systems market?
• Which regions are witnessing the highest adoption of leadless pacing systems?
• How do technological advancements influence the competitive landscape of the market?
• Who are the leading players in the leadless pacing systems market, and what strategies are they employing to maintain market dominance?
• What are the emerging trends and future prospects in the global leadless pacing systems market?

Competitive Intelligence and Business Strategy:

Leading companies in the global leadless pacing systems market, including St. Jude's Medical (now Abbott) and Medtronic plc, are focusing on product innovation, strategic acquisitions, and regulatory approvals to stay competitive. These companies are investing in R&D to enhance the performance of leadless pacing devices and expand their product offerings. Collaboration with healthcare providers and improving professional training are key to expanding their market reach. As the market evolves, companies are focusing on technological advancements such as multi-chamber pacing systems to differentiate their products and offer additional value to patients.

Key Companies Profiled:

• Abbott Laboratories (St. Jude Medical)
• Medtronic plc
• Others

Leadless Pacing Systems Market Segmentation:

By Application:

• Atrial Fibrillation
• Sinus Node Dysfunction
• Atrioventricular Block
• Others

By End User:

• Hospitals
• Ambulatory Surgical Centers

By Region:

• North America
• Europe
• Asia Pacific
• Latin America
• Middle East & Africa

Table of Contents

1. Executive Summary

• 1.1. Market Overview
• 1.2. Market Analysis
• 1.3. PMR Analysis and Recommendations
• 1.4. Wheel of Fortune

2. Market Introduction

• 2.1. Market Definition
• 2.2. Market Taxonomy
• 2.3. Leadless Pacing System Advantages
• 2.4. Approvals Road Map

3. Leadless Pacing System Market View Point

• 3.1. Global Market Dynamics
  • 3.1.1. Drivers
  • 3.1.2. Restraints
  • 3.1.3. Trends
• 3.2. Macro-Economic Factors
• 3.3. Opportunity Analysis

4. North America Leadless Pacing System Market Analysis 2019-2023 and Forecast 2024-2031

• 4.1. Introduction
• 4.2. Pricing Analysis
• 4.3. Market Volume Analysis
• 4.4. Market Size (US$ Mn) Forecast By Country, 2024-2031
  • 4.4.1. U.S.
  • 4.4.2. Canada
• 4.5. Market Size (US$ Mn) Forecast By Application Type, 2024-2031
  • 4.5.1. Atrial Fibrillation
  • 4.5.2. Sinus Node Dysfunction
  • 4.5.3. Atrioventricular Block
  • 4.5.4. Others
• 4.6. Market Size (US$ Mn) Forecast By End user, 2024-2031
  • 4.6.1. Hospitals
  • 4.6.2. Ambulatory surgical centers
• 4.7. Market Attractiveness Analysis
  • 4.7.1. By Application Type
  • 4.7.2. By End user
  • 4.7.3. By Country

5. Latin America Leadless Pacing System Market Analysis 2019-2023 and Forecast 2024-2031

• 5.1. Introduction
• 5.2. Pricing Analysis
• 5.3. Market Volume Analysis
• 5.4. Market Size (US$ Mn) Forecast By Country, 2024-2031
  • 5.4.1. Brazil
  • 5.4.2. Mexico
  • 5.4.3. Rest of Latin America
• 5.5. Market Size (US$ Mn) Forecast By Application Type, 2024-2031
  • 5.5.1. Atrial Fibrillation
  • 5.5.2. Sinus Node Dysfunction
  • 5.5.3. Atrioventricular Block
  • 5.5.4. Others
• 5.6. Market Size (US$ Mn) Forecast By End user, 2024-2031
  • 5.6.1. Hospitals
  • 5.6.2. Ambulatory surgical centers
• 5.7. Market Attractiveness Analysis
  • 5.7.1. By Application Type
  • 5.7.2. By End user
  • 5.7.3. By Country

6. Europe Leadless Pacing System Market Analysis 2019-2023 and Forecast 2024-2031

• 6.1. Introduction
• 6.2. Pricing Analysis
• 6.3. Market Volume Analysis
• 6.4. Market Size (US$ Mn) Forecast By Country, 2024-2031
  • 6.4.1. Germany
  • 6.4.2. U.K.
  • 6.4.3. France
  • 6.4.4. Italy
  • 6.4.5. Spain
  • 6.4.6. Rest of Europe
• 6.5. Market Size (US$ Mn) Forecast By Application Type, 2024-2031
  • 6.5.1. Atrial Fibrillation
  • 6.5.2. Sinus Node Dysfunction
  • 6.5.3. Atrioventricular Block
  • 6.5.4. Others
• 6.6. Market Size (US$ Mn) Forecast By End user, 2024-2031
  • 6.6.1. Hospitals
  • 6.6.2. Ambulatory surgical centers
• 6.7. Market Attractiveness Analysis
  • 6.7.1. By Application Type
  • 6.7.2. By End user
  • 6.7.3. By Country

7. Asia Pacific (APAC) Leadless Pacing System Market Analysis 2019-2023 and Forecast 2024-2031

• 7.1. Introduction
• 7.2. Pricing Analysis
• 7.3. Market Volume Analysis
• 7.4. Market Size (US$ Mn) Forecast By Country, 2024-2031
  • 7.4.1. China
  • 7.4.2. India
  • 7.4.3. Japan
  • 7.4.4. Australia and New Zealand
  • 7.4.5. Rest of APAC
• 7.5. Market Size (US$ Mn) Forecast By Application Type, 2024-2031
  • 7.5.1. Atrial Fibrillation
  • 7.5.2. Sinus Node Dysfunction
  • 7.5.3. Atrioventricular Block
  • 7.5.4. Others
• 7.6. Market Size (US$ Mn) Forecast By End user, 2024-2031
  • 7.6.1. Hospitals
  • 7.6.2. Ambulatory surgical centers
• 7.7. Market Attractiveness Analysis
  • 7.7.1. By Application Type
  • 7.7.2. By End user
  • 7.7.3. By Country

8. Middle East and Africa (MEA) Leadless Pacing System Market Analysis 2019-2023 and Forecast 2024-2031

• 8.1. Introduction
• 8.2. Pricing Analysis
• 8.3. Market Volume Analysis
• 8.4. Market Size (US$ Mn) Forecast By Country, 2024-2031
  • 8.4.1. GCC Countries
  • 8.4.2. South Africa
  • 8.4.3. Rest of MEA
• 8.5. Market Size (US$ Mn) Forecast By Application Type, 2024-2031
  • 8.5.1. Atrial Fibrillation
  • 8.5.2. Sinus Node Dysfunction
  • 8.5.3. Atrioventricular Block
  • 8.5.4. Others
• 8.6. Market Size (US$ Mn) Forecast By End user, 2024-2031
  • 8.6.1. Hospitals
  • 8.6.2. Ambulatory surgical centers
• 8.7. Market Attractiveness Analysis
  • 8.7.1. By Application Type
  • 8.7.2. By End user
  • 8.7.3. By Country

9. Competition Landscape

• 9.1. Competition Dashboard
• 9.2. Market Share Analysis (2024)
• 9.3. Company Profiles (Details - Overview, Financials, Strategy, Recent Developments)
• 9.4. Key Players
  • 9.4.1. Abbott Laboratories
  • 9.4.2. Medtronic Plc

10. Global Leadless Pacing System Market Analysis 2019-2023 and Forecast 2024-2031, By Region

• 10.1. Introduction
  • 10.1.1. Market Share Analysis By Region
  • 10.1.2. Y-o-Y Growth Projections By Region
• 10.2. Market Size Analysis 2024-2031, By Region
  • 10.2.1. North America
  • 10.2.2. Latin America
  • 10.2.3. Europe
  • 10.2.4. Asia Pacific (APAC)
  • 10.2.5. Middle East and Africa (MEA)
• 10.3. Market Attractiveness Analysis By Region

11. Global Leadless Pacing System Market Analysis 2019-2023 and Forecast 2024-2031, By Application Type

• 11.1. Introduction
  • 11.1.1. Market Share Analysis By Application Type
  • 11.1.2. Y-o-Y Growth Projections By Application Type
• 11.2. Market Size Analysis 2024-2031, By Application Type
  • 11.2.1. Atrial Fibrillation
  • 11.2.2. Sinus Node Dysfunction
  • 11.2.3. Atrioventricular Block
  • 11.2.4. Others
• 11.3. Market Attractiveness Analysis By Application Type

12. Global Leadless Pacing System Market Analysis 2019-2023 and Forecast 2024-2031, By End User

• 12.1. Introduction
  • 12.1.1. Market Share Analysis By End User
  • 12.1.2. Y-o-Y Growth Projections By End User
• 12.2. Market Size Analysis 2024-2031, By End User
  • 12.2.1. Hospitals
  • 12.2.2. Ambulatory surgical centers
• 12.3. Market Attractiveness Analysis By End User

13. Global Leadless Pacing System Market Analysis 2019-2023 and Forecast 2024-2031

• 13.1. Market Size and Y-o-Y Growth
• 13.2. Market Volume Analysis
• 13.3. Absolute $ Opportunity

14. Assumptions and Acronyms Used

15. Research Methodology

관련자료